179 related articles for article (PubMed ID: 10918410)
21. High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors.
Rosenthal J; Bolotin E; Shakhnovits M; Pawlowska A; Falk P; Qian D; Oliver C; Sato J; Miser J; Forman S
Bone Marrow Transplant; 2008 Sep; 42(5):311-8. PubMed ID: 18587438
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors.
Lucidarme N; Valteau-Couanet D; Oberlin O; Couanet D; Kalifa C; Beaujean F; Lapierre V; Hartmann O
Bone Marrow Transplant; 1998 Sep; 22(6):535-40. PubMed ID: 9758339
[TBL] [Abstract][Full Text] [Related]
23. Malignant tumors of children and adolescents.
Kalwinsky DK
Cancer Chemother Biol Response Modif; 1994; 15():646-64. PubMed ID: 7779605
[No Abstract] [Full Text] [Related]
24. Blood leukocyte subsets and cytokine profile after autologous peripheral blood stem cell transplantation.
Krause SW; Rothe G; Gnad M; Reichle A; Andreesen R
Ann Hematol; 2003 Oct; 82(10):628-36. PubMed ID: 12961030
[TBL] [Abstract][Full Text] [Related]
25. Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors.
Fraser CJ; Weigel BJ; Perentesis JP; Dusenbery KE; DeFor TE; Baker KS; Verneris MR
Bone Marrow Transplant; 2006 Jan; 37(2):175-81. PubMed ID: 16273111
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
27. [Current problems of solid tumors in childhood].
Plüss HJ; Sartorius J; Wagner HP; Wyss M
Schweiz Med Wochenschr; 1974 May; 104(18):634-41. PubMed ID: 4363542
[No Abstract] [Full Text] [Related]
28. [Autologous bone marrow graft in solid tumors in childhood].
Devalck C; Ferster A; De Laet MH; Nafa S; Bujan W; Azzi N; Ben Salah H; Corrazza F; Vergauwen P; Sariban E
Rev Med Brux; 1992 Jun; 13(6):201-6. PubMed ID: 1321485
[TBL] [Abstract][Full Text] [Related]
29. Myeloablative therapy, stem cell rescue and gene transfer in advanced Ewing tumors.
Burdach S; Nürnberger W; Laws HJ; Engel BC; Dirksen U; Krauth K; Pape H; Kahn T; Körholz D; Gadner H; Göbel U; Jürgens H
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S67-8. PubMed ID: 8899179
[No Abstract] [Full Text] [Related]
30. Total parenteral nutrition in children and adolescents treated with high-dose chemotherapy followed by autologous haematopoietic transplants.
Wedrychowicz A; Spodaryk M; Krasowska-Kwiecień A; Goździk J
Br J Nutr; 2010 Mar; 103(6):899-906. PubMed ID: 19860986
[TBL] [Abstract][Full Text] [Related]
31. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.
Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y
Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358
[TBL] [Abstract][Full Text] [Related]
32. Current concepts in cancer. Solid tumors in children.
Maurer HM
N Engl J Med; 1978 Dec; 299(24):1345-8. PubMed ID: 213716
[No Abstract] [Full Text] [Related]
33. Neuropsychological outcome in long-term survivors of a childhood extracranial solid tumor who have undergone autologous bone marrow transplantation.
Notteghem P; Soler C; Dellatolas G; Kieffer-Renaux V; Valteau-Couanet D; Raimondo G; Hartmann O
Bone Marrow Transplant; 2003 Apr; 31(7):599-606. PubMed ID: 12692628
[TBL] [Abstract][Full Text] [Related]
34. IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.
Burns LJ; Weisdorf DJ; DeFor TE; Vesole DH; Repka TL; Blazar BR; Burger SR; Panoskaltsis-Mortari A; Keever-Taylor CA; Zhang MJ; Miller JS
Bone Marrow Transplant; 2003 Jul; 32(2):177-86. PubMed ID: 12838283
[TBL] [Abstract][Full Text] [Related]
35. [Immune stimulation with interleukin-2 after autologous stem cell transplantation in children and adolescents with solid tumors].
Laws HJ; Dilloo D; Hanenberg H; Schwamborn D; Burdach S; Göbel U
Klin Padiatr; 1993; 205(4):257-63. PubMed ID: 8104258
[TBL] [Abstract][Full Text] [Related]
36. High-dose chemotherapy and autologous peripheral blood stem cell transfusion for adult and adolescent patients with small round cell sarcomas.
Yamada K; Takahashi M; Ogura M; Kagami Y; Taji H; Kamiya Y; Sugiura H; Morishima Y
Bone Marrow Transplant; 2007 Apr; 39(8):471-6. PubMed ID: 17334381
[TBL] [Abstract][Full Text] [Related]
37. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.
Shankar AG; Ashley S; Craft AW; Pinkerton CR
Med Pediatr Oncol; 2003 Mar; 40(3):141-7. PubMed ID: 12518341
[TBL] [Abstract][Full Text] [Related]
38. Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation.
Nomura S; Ishii K; Inami N; Uoshima N; Ishida H; Yoshihara T; Kitayama H; Hayashi K
Transpl Immunol; 2007 Nov; 18(2):115-21. PubMed ID: 18005854
[TBL] [Abstract][Full Text] [Related]
39. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in an intensive treatment program for children with Ewing's sarcoma.
Luksch R; Massimino M; Cefalo G; Lombardi F; Ferrari A; Casanova M; Gandola L; Terenziani M; Spreafico F; Fossati-Bellani F
Haematologica; 2001 Jul; 86(7):753-60. PubMed ID: 11454532
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of combination thalidomide/interleukin-2 therapy plus granulocyte macrophage-colony stimulating factor in patients with metastatic renal cell carcinoma.
Amato RJ; Malya R; Rawat A
Am J Clin Oncol; 2008 Jun; 31(3):237-43. PubMed ID: 18525301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
